at prestige brands, now prestige consumer healthcare, we focus on product innovation and quality in over-the-counter healthcare products to improve the lives of our customers worldwide. you may not know who prestige consumer healthcare is, but you know and use our products: clear eyes, dentek, summer's eve, monistat, bc, goody's, dramamine, and many more. for generations, our trusted brands have helped consumers care for themselves and their loved ones. our mission is to preserve this trust by continuing to provide products stewarded with our customer needs in mind. prestige consumer healthcare is a different kind of company. we are the largest independent provider of over-the-counter healthcare products in north america yet we are nimble enough to give detailed attention to each and every one of our product offerings. we are constantly improving, creating products that match the ever-changing lifestyles and needs of people and families everywhere. prestige’s success as a company is th
Company profile
Ticker
PBH
Exchange
Website
CEO
Ronald M. Lombardi
Employees
Location
Fiscal year end
Industry (SIC)
Former names
Prestige Brands Holdings, Inc.
SEC CIK
Corporate docs
Subsidiaries
of Prestige Consumer Healthcare Inc. • Blacksmith Brands, Inc. • C.B. Fleet Company, Incorporated • C.B. Fleet Investment Corporation • C.B. Fleet International LLC • C.B. Fleet International(s) Pte. Ltd • Care Acquisition Company Pty Limited • Care Pharmaceuticals Pty Limited • Cellegy Australia • Clear Eyes Pharma Limited ...
IRS number
201297589
PBH stock data
Latest filings (excl ownership)
10-Q
2024 Q3
Quarterly report
8 Feb 24
8-K
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
8 Feb 24
8-K
Entry into a Material Definitive Agreement
13 Dec 23
10-Q
2024 Q2
Quarterly report
2 Nov 23
8-K
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
2 Nov 23
10-Q
2024 Q1
Quarterly report
3 Aug 23
8-K
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results
3 Aug 23
ARS
2022 FY
Annual report to shareholders
29 Jun 23
DEF 14A
Definitive proxy
29 Jun 23
10-K
2023 FY
Annual report
5 May 23
Transcripts
PBH
Earnings call transcript
2024 Q3
8 Feb 24
PBH
Earnings call transcript
2024 Q2
2 Nov 23
PBH
Earnings call transcript
2024 Q1
3 Aug 23
PBH
Earnings call transcript
2023 Q4
4 May 23
PBH
Earnings call transcript
2023 Q4
4 May 23
PBH
Earnings call transcript
2023 Q3
2 Feb 23
PBH
Earnings call transcript
2023 Q2
3 Nov 22
PBH
Earnings call transcript
2023 Q1
7 Aug 22
PBH
Earnings call transcript
2022 Q4
6 May 22
PBH
Earnings call transcript
2022 Q3
3 Feb 22
Latest ownership filings
4
Mary Beth Fritz
5 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
4
Mary Beth Fritz
29 Feb 24
144
Notice of proposed sale of securities
28 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
4
Mary Beth Fritz
27 Feb 24
144
Notice of proposed sale of securities
26 Feb 24
144
Notice of proposed sale of securities
23 Feb 24
4
Adel Mekhail
20 Feb 24
4
Christine Sacco
16 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 60.07 mm | 60.07 mm | 60.07 mm | 60.07 mm | 60.07 mm | 60.07 mm |
Cash burn (monthly) | (no burn) | (no burn) | (no burn) | 1.70 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | n/a | 11.74 mm | n/a | n/a |
Cash remaining | n/a | n/a | n/a | 48.33 mm | n/a | n/a |
Runway (months of cash) | n/a | n/a | n/a | 28.5 | n/a | n/a |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 272 |
Opened positions | 30 |
Closed positions | 29 |
Increased positions | 96 |
Reduced positions | 112 |
13F shares | Current |
---|---|
Total value | 2.86 tn |
Total shares | 50.20 mm |
Total puts | 1.30 k |
Total calls | 4.20 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 8.80 mm | $503.28 bn |
Vanguard | 5.69 mm | $325.57 bn |
Dimensional Fund Advisors | 3.60 mm | $206.06 bn |
MCQEF Macquarie | 3.12 mm | $178.44 bn |
Ariel Investments | 2.53 mm | $144.96 bn |
STT State Street | 1.91 mm | $109.34 bn |
WHG Westwood | 1.24 mm | $71.30 bn |
IVZ Invesco | 1.19 mm | $68.34 bn |
Massachusetts Financial Services | 1.10 mm | $63.00 bn |
Geode Capital Management | 1.10 mm | $62.73 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | Fritz Mary Beth | Common Stock, par value $0.01 per share | Sell | Dispose S | No | No | 70.41 | 110 | 7.75 k | 15,934 |
1 Mar 24 | Fritz Mary Beth | Common Stock, par value $0.01 per share | Option exercise | Acquire M | No | No | 30.56 | 110 | 3.36 k | 16,044 |
1 Mar 24 | Fritz Mary Beth | Common Stock, par value $0.01 per share | Sell | Dispose S | No | No | 70.43 | 62 | 4.37 k | 15,934 |
1 Mar 24 | Fritz Mary Beth | Common Stock, par value $0.01 per share | Option exercise | Acquire M | No | No | 57.18 | 62 | 3.55 k | 15,996 |
1 Mar 24 | Fritz Mary Beth | Employee Stock Options Common Stock | Option exercise | Dispose M | No | No | 30.56 | 110 | 3.36 k | 0 |
1 Mar 24 | Fritz Mary Beth | Employee Stock Options Common Stock | Option exercise | Dispose M | No | No | 57.18 | 62 | 3.55 k | 0 |
26 Feb 24 | Fritz Mary Beth | Common Stock, par value $0.01 per share | Sell | Dispose S | No | No | 70.44 | 4,545 | 320.15 k | 15,934 |
26 Feb 24 | Fritz Mary Beth | Common Stock, par value $0.01 per share | Option exercise | Acquire M | No | No | 30.56 | 4,545 | 138.90 k | 20,479 |
26 Feb 24 | Fritz Mary Beth | Common Stock, par value $0.01 per share | Sell | Dispose S | No | No | 70.43 | 5,132 | 361.45 k | 15,934 |
26 Feb 24 | Fritz Mary Beth | Common Stock, par value $0.01 per share | Option exercise | Acquire M | No | No | 57.18 | 5,132 | 293.45 k | 21,006 |
Press releases
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
25 Apr 24
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
8 Feb 24
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
2 Feb 24